Duncker Streett & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-500
| Closed | -$3.52K | – | 491 |
|
|
2023
Q2 | $3.52K | Hold |
500
| – | – | ﹤0.01% | 447 |
|
|
2023
Q1 | $4.17K | Hold |
500
| – | – | ﹤0.01% | 429 |
|
|
2022
Q4 | $5.74K | Hold |
500
| – | – | ﹤0.01% | 432 |
|
|
2022
Q3 | $6K | Hold |
500
| – | – | ﹤0.01% | 414 |
|
|
2022
Q2 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 425 |
|